FINWIRES · TerminalLIVE
FINWIRES

SHIFT, Rise Consulting Group Deepen Partnership

By

SHIFT (TYO:3697) and its equity-method affiliate Rise Consulting (TYO:9168) have agreed to expand their business collaboration across talent, sales, delivery, and AI, according to a Tokyo bourse filing on Friday.

The latest partnership builds on a capital and business alliance first signed in April 2025.

Through this expanded partnership, SHIFT will support Rise's recruiting, project staffing, and joint proposal development.

Rise, in turn, will tap into SHIFT's operational frameworks and networks.

Initial joint efforts have already produced three co-developed service offerings, including AI-powered system modernization and business process innovation.

Both companies expect to drive mutual business growth and enhance corporate value while maintaining their independence as publicly listed firms.

Related Articles

Asia

Update: Web Travel Group CEO Sells Nearly AU$7 Million Shares to Settle Financing Arrangements With UBS

(Updates to add stock movement in the last paragraph)Web Travel Group (ASX:WEB) said its chief executive and managing director, John Guscic, sold 2.7 million fully paid ordinary shares for a consideration of AU$6.9 million in order to to settle amounts owed to UBS under previously disclosed funding arrangements, according to an Australian bourse filing on May 29 after hours.The funding arrangements included options and stock loans referencing 2.7 million Web Travel Group shares.The company's shares fell past 2% in recent Monday trade.

$ASX:WEB
Asia

Epiminder Reaches 25 Enrolled Patients in Epilepsy Study

Epiminder (ASX:EPI) reached 25 enrolled patients in its DETECT (Diagnosing Epilepsy To EffeCT change) clinical study in the US, according to a Monday filing with the Australian bourse.The study is evaluating the Minder system, an implantable device for continuous monitoring of brain activity, as a tool to improve clinical decision-making for patients with epilepsy after an inconclusive prolonged electroencephalographic monitoring assessment, the filing said.The company is progressing toward its next enrolment target of 50 patients, expected in the third quarter of the year, and is on track to meet its stated target of 210 patients by the end of the first half of 2027, per the filing.

$ASX:EPI
Asia

Update: Australian Unity Office Fund Completes Sale of Brisbane Asset; Expects Delisting on June 9

(Updates to add stock movement in the last paragraph)Australian Unity Office Fund (ASX:AOF) said it sold its 150 Charlotte Street, Brisbane, asset at a gross sale price of AU$40 million on May 29, according to an Australian bourse filing on May 29 after hours.The company's responsible entity, Australian Unity Investment Real Estate (AUIREL), plans to apply for Australian Unity Office Fund's units to be suspended from trading at the close of trading on Wednesday, and expects the company to be delisted from the Australian Securities Exchange on June 9.AUIREL expects to return aggregate proceeds to the company's shareholders of between AU$0.37 and AU$0.38 per unit as soon as practicable after the delisting. As part of the compulsory redemption, AUIREL will redeem 19 Australian Unity Office Fund units for every 20 units held by a unit holder on the June 10 record date, with payment expected before the end of June.Meanwhile, under a winding up process for the real estate investment trust, AUIREL expects to make a final return of proceeds to Australian Unity Office Fund unit holders in the second half of the year, reflecting the company's residual cash after allowing for all liabilities and funding the wind-up costs.The company's shares fell around 1% in recent Monday trade.

$ASX:AOF